Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues CPF Q1 2026 Earnings EPS Beats Estimates by 44 Amid Solid Operating Performance RLI Q1 2026 Earnings EPS Beats by Nearly 5 as Underwriting Disciplines Deliver COSO Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher on Resilient Fundamentals Flowers Foods Q1 2026 Earnings EPS Surges Past Estimates as Stock Jumps 13 Erie Indemnity ERIE Shows Modest Decline as Price Consolidates Near Key Support REMAX Holdings RMAX Edges Higher as Housing Market Uncertainty Lingers Harvard Ave Acquisition Corporation Unit HAVAU Holds Steady at 1028 Amid Limited Trading Activity Bunge Limited BG Rises 13 Key Levels and Sector Strength LCI Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain